Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NRXPW | US
0
0%
Healthcare
Biotechnology
30/06/2024
17/03/2026
0.02
0.01
0.03
0.01
NRX Pharmaceuticals Inc. a clinical-stage pharmaceutical company develops novel therapeutics for the treatment of central nervous system disorders. Its products include ZYESAMI an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-100 and NRX-101 oral therapeutics that is in phase IIb/III clinical trials for the treatment of bipolar depression in patients with acute suicidal behavior/ideation and sub-acute suicidal ideation and behavior. The company was founded in 2015 and is based in Wilmington Delaware.
View LessLow Debt to Equity (< 0.25)
Price Below SMA10D
High Short-term Volatility
High 6-Month Volatility (>65%)
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
362.0%1 month
316.7%3 months
293.1%6 months
301.8%-
-
-
-0.47
1.63
-
-
-
-23.26M
335.10M
335.10M
-
-
-
-
-682.61
-
-
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.03
Range1M
0.04
Range3M
0.08
Rel. volume
0.15
Price X volume
106.37
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Cellectis S.A | CLLS | Biotechnology | 3.45 | 360.76M | -1.43% | n/a | 74.14% |
| SIGA Technologies Inc | SIGA | Biotechnology | 5.02 | 358.27M | -8.06% | 5.91 | 0.97% |
| Bicycle Therapeutics Limited | BCYC | Biotechnology | 5.07 | 349.80M | 0.40% | n/a | 4.89% |
| NextCure Inc | NXTC | Biotechnology | 12.32 | 344.66M | 3.01% | n/a | 7.21% |
| Absci Corporation Common Stock | ABSI | Biotechnology | 3.03 | 344.07M | 21.20% | n/a | 6.02% |
| Cerus Corporation | CERS | Biotechnology | 1.8 | 333.53M | 0.00% | n/a | 199.34% |
| Regulus Resources Inc | RGLSF | Biotechnology | 2.65 | 332.55M | n/a | 0.00% | |
| Nautilus Biotechnology Inc. | NAUT | Biotechnology | 2.65 | 332.34M | 10.88% | n/a | 13.86% |
| AC Immune SA | ACIU | Biotechnology | 3.32 | 328.48M | 6.07% | n/a | 0.00% |
| Xilio Therapeutics Inc. Common Stock | XLO | Biotechnology | 7.43 | 326.57M | -3.00% | n/a | 25.98% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| MCBC Holdings Inc | MCFT | Recreational Vehicles | 19.99 | 331.98M | 0.60% | 34.27 | 26.82% |
| ACCO Brands Corporation | ACCO | Building Products & Equipment | 3.21 | 307.51M | -0.93% | n/a | 174.23% |
| Urban One Inc | UONEK | Broadcasting - Radio | 5.65 | 299.49M | -0.53% | n/a | 268.43% |
| Camping World Holdings Inc | CWH | Recreational Vehicles | 6.26 | 282.51M | 0.00% | n/a | 3644.76% |
| Marine Products Corporation | MPX | Recreational Vehicles | 7.14 | 247.88M | 0.14% | 13.23 | 0.00% |
| CPI Card Group Inc | PMTS | Building Products & Equipment | 14.45 | 161.23M | -2.82% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 8.6 | 138.09M | -0.06% | n/a | 286.96% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 6.26 | 101.97M | -0.16% | 9.09 | 39.79% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.9 | 100.23M | 0.58% | 5.16 | 19.82% |
| Saga Communications Inc | SGA | Broadcasting - Radio | 11.16 | 69.88M | -1.24% | 14.48 | 7.10% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | - | 0.53 | - |
| Ent. to Revenue | - | 3,967.00 | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | - | 15.55 | - |
| Dividend Yield | - | 2.20 | - |
| Std. Deviation (3M) | 293.11 | 72.80 | Riskier |
| Debt to Equity | -0.47 | -1.23 | Expensive |
| Debt to Assets | 1.63 | 0.25 | Expensive |
| Market Cap | 335.10M | 3.66B | Emerging |